DiaCarta Reports Positive Clinical Trial Data for Its Blood Based Test To Triage FIT-Positive Patients Enrolled in CRC Screening Programs
UF Innovate | Sid Martin Biotech alum DiaCarta Inc. has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical test)-positive patients in colorectal cancer (CRC) screening.
Campylobacter Presence in CRC Found To Accelerate Tumor Metastasis
UF researcher Christian Jobin found that campylobacter bacteria have been found to be enriched in primary CRC lesions of patients with metastasis.
